DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,104 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $82,681,611 | -3.1% | 330,925 | -3.2% | 0.32% | -3.0% |
Q1 2024 | $85,342,060 | +8.0% | 341,751 | +0.1% | 0.33% | -1.5% |
Q4 2023 | $79,011,632 | -7.7% | 341,539 | -1.1% | 0.34% | -16.2% |
Q3 2023 | $85,640,150 | +2.7% | 345,184 | -0.7% | 0.40% | +7.2% |
Q2 2023 | $83,408,640 | -15.2% | 347,536 | -11.0% | 0.37% | -12.4% |
Q1 2023 | $98,381,294 | -8.8% | 390,340 | -4.0% | 0.43% | -9.4% |
Q4 2022 | $107,890,576 | +0.9% | 406,490 | -1.8% | 0.47% | -5.4% |
Q3 2022 | $106,947,000 | +2.6% | 414,059 | +0.7% | 0.50% | +10.9% |
Q2 2022 | $104,227,000 | -12.8% | 411,121 | +0.9% | 0.45% | +2.3% |
Q1 2022 | $119,515,000 | -10.8% | 407,441 | +0.0% | 0.44% | -6.2% |
Q4 2021 | $134,015,000 | +6.1% | 407,328 | -1.8% | 0.47% | -1.3% |
Q3 2021 | $126,279,000 | +9.7% | 414,792 | -3.3% | 0.47% | +14.0% |
Q2 2021 | $115,078,000 | +18.1% | 428,818 | -1.0% | 0.42% | +12.8% |
Q1 2021 | $97,465,000 | +72.9% | 433,022 | +70.7% | 0.37% | +65.8% |
Q4 2020 | $56,359,000 | +2.9% | 253,709 | -0.3% | 0.22% | -11.9% |
Q3 2020 | $54,796,000 | +15.2% | 254,473 | -5.4% | 0.25% | +9.6% |
Q2 2020 | $47,576,000 | +22.3% | 269,048 | -4.3% | 0.23% | +6.5% |
Q1 2020 | $38,896,000 | -9.8% | 281,020 | +0.0% | 0.22% | +13.1% |
Q4 2019 | $43,121,000 | +6.8% | 280,954 | +0.5% | 0.19% | -1.0% |
Q3 2019 | $40,381,000 | -3.8% | 279,589 | -4.8% | 0.19% | -1.5% |
Q2 2019 | $41,991,000 | +8.7% | 293,811 | +0.4% | 0.20% | +4.3% |
Q1 2019 | $38,624,000 | +31.9% | 292,563 | +3.0% | 0.19% | +16.8% |
Q4 2018 | $29,284,000 | -5.1% | 283,977 | 0.0% | 0.16% | +10.3% |
Q3 2018 | $30,857,000 | +8.5% | 283,977 | -1.5% | 0.15% | +5.0% |
Q2 2018 | $28,451,000 | -0.9% | 288,318 | -1.7% | 0.14% | -2.1% |
Q1 2018 | $28,712,000 | -39.4% | 293,252 | -42.6% | 0.14% | -38.0% |
Q4 2017 | $47,417,000 | +8.2% | 510,848 | +0.0% | 0.23% | +0.4% |
Q3 2017 | $43,815,000 | +1.7% | 510,787 | +0.1% | 0.23% | -1.7% |
Q2 2017 | $43,069,000 | -1.1% | 510,362 | +0.2% | 0.23% | -3.3% |
Q1 2017 | $43,544,000 | +9.4% | 509,105 | -0.4% | 0.24% | +3.9% |
Q4 2016 | $39,787,000 | -2.7% | 511,142 | -2.0% | 0.23% | -2.9% |
Q3 2016 | $40,884,000 | -30.3% | 521,543 | -10.2% | 0.24% | -30.6% |
Q2 2016 | $58,647,000 | +6.4% | 580,660 | -0.1% | 0.34% | +4.9% |
Q1 2016 | $55,132,000 | +1.6% | 581,196 | -0.5% | 0.33% | +2.5% |
Q4 2015 | $54,277,000 | +4.3% | 584,375 | -4.3% | 0.32% | +1.9% |
Q3 2015 | $52,034,000 | -3.3% | 610,658 | -2.8% | 0.31% | +7.2% |
Q2 2015 | $53,791,000 | +0.4% | 628,476 | -0.4% | 0.29% | +1.0% |
Q1 2015 | $53,591,000 | -1.4% | 631,223 | -0.4% | 0.29% | 0.0% |
Q4 2014 | $54,340,000 | +12.8% | 633,994 | -0.0% | 0.29% | +7.0% |
Q3 2014 | $48,181,000 | -4.6% | 634,125 | -1.1% | 0.27% | -3.9% |
Q2 2014 | $50,505,000 | +5.9% | 641,502 | +0.9% | 0.28% | +1.8% |
Q1 2014 | $47,692,000 | -2.2% | 635,896 | +0.7% | 0.28% | -4.5% |
Q4 2013 | $48,752,000 | +11.4% | 631,503 | +0.1% | 0.29% | +4.0% |
Q3 2013 | $43,748,000 | +11.9% | 631,102 | +2.1% | 0.28% | +6.1% |
Q2 2013 | $39,111,000 | +2.6% | 617,869 | +0.7% | 0.26% | -0.4% |
Q1 2013 | $38,133,000 | – | 613,564 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |